Local pharma producer Antibiotice is planning a significant investment in the research, development, and production of critical medicines, with a proposed RON 376.8 million.
Ceres Pharma, a Belgian pharmaceutical group, has announced the official completion of the integration process between its Romanian subsidiaries, Dacia Plant and Viva Pharma.
Novartis has over 550 employees in Romania and operates a manufacturing unit in the country.
Turnover was approximately RON 231 million in the first nine months of the year.
Opening of STADA production and supply-chain hub in Turda, Romania, strengthens European security of supply with more than 150 million packs of medicines per year.
Romania emerged as the most dynamic mergers and acquisitions (M&A) market in Central and Eastern Europe (CEE), recording 9% growth in transaction numbers during 2025.
Several EU member states have already implemented substantial tax cuts—specifically excise duties and VAT—to mitigate the impact of the fuel crisis on their economies.
Romania's Ministry of Investments and European Projects (MIPE) and the Investment and Development Bank (BID) signed a financing agreement on 30 March 2026 for the Just Transition Participation Fund (FPTJ).
Hanwha Aerospace Romania has presented an industrial package worth €1.3 billion aimed at strengthening Romania's defence capabilities and positioning the country as a production and innovation centre in the European defence industry.
Banca Transilvania, Romania's banking leader, has completed its largest cross-border financing to date with a €50 million loan for Hampton by Hilton Venice Isola Nuova. The loan, provided through BT Italia branch, refinances the hotel's development costs.